This website uses cookies to make the offer more user-friendly and effective. Please agree to the use of cookies in order to be able to use all functions of the website.Further information

Inside Medical Technology

11 - 12 April 2018 // Nuremberg, Germany

This is what MT-CONNECT and MedTech Summit 2018 have to offer.

back to day overview
Drug Delivery

N2B-patch - Formulations for intranasal delivery of drugs Vortragssprache Deutsch Simultanübersetzung Englisch

As a project coordinator, the Fraunhofer IGB is involved in the development of a medical therapy for the administration of active ingredients via the olfactoria region within the EU-funded project »N2B-patch«. Within the project, the Fraunhofer IGB focuses on the formulation of the particles containing the active substance and the embedding of these particles into hydrogels.

A key factor in the development of functional ingredients or active substances is their transport to their target location. The Fraunhofer IGB is working on particle-based formulations for the transport of these substances to the site of action in a targeted manner (drug delivery) and to deliver them in a controlled manner (drug release). Medically active substances are normally distributed via the blood – either directly by injection into the bloodstream or indirectly, for example through the digestive tract after oral administration. In many diseases, however – for example of the central nervous system – it is of decisive importance to transport the active substance as efficiently as possible to the required target site. An example of this is the treatment of multiple sclerosis, where the pharmaceutical agents have to produce their effect above all in the central nervous system. However, this is especially difficult to achieve in the usual way via the blood due to special protective mechanisms such as the blood-brain barrier. Within the scope of the EU-funded “N2B patch” cooperative project, Fraunhofer IGB is therefore participating in the development of a medical form of therapy that delivers the drug via the Regio olfactoria. The therapeutic system will consist of the active agent itself, of a formulation containing the active agent, a hydrogel as carrier material for the formulation, and a suitable applicator. In the project the Fraunhofer IGB is concentrating on the formulation of the particles containing the active agent, and on inserting these particles into hydrogels.

--- Date: 12.04.2018 Time: 1:25 PM - 1:50 PM Location: Hall Brüssel II, NCC Mitte

Main speaker

Dr. Carmen Gruber-Traub

Dr. Carmen Gruber-Traub

/ Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB


The selected entry has been placed in your favourites!

If you register you can save your favourites permanently and access all entries even when underway – via laptop or tablet.

You can register an account here to save your settings in the Exhibitors and Products Database and as well as in the Supporting Programme.The registration is not for the TicketShop and ExhibitorShop.

Register now

Your advantages at a glance:

  • Advantage Save your favourites permanently. Use the instant access to exhibitors or products saved – mobile too, anytime and anywhere – incl. memo function.
  • Advantage The optional newsletter gives you regular up-to-date information about new exhibitors and products – matched to your interests.
  • Advantage Call up your favourites mobile too! Simply log in and access them at anytime.